Oragenics Balance Sheet Health
Financial Health criteria checks 5/6
Oragenics has a total shareholder equity of $3.2M and total debt of $312.7K, which brings its debt-to-equity ratio to 9.9%. Its total assets and total liabilities are $5.0M and $1.8M respectively.
Key information
9.9%
Debt to equity ratio
US$312.70k
Debt
Interest coverage ratio | n/a |
Cash | US$3.48m |
Equity | US$3.17m |
Total liabilities | US$1.80m |
Total assets | US$4.97m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: OGEN's short term assets ($3.9M) exceed its short term liabilities ($1.8M).
Long Term Liabilities: OGEN has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: OGEN has more cash than its total debt.
Reducing Debt: OGEN's debt to equity ratio has increased from 0.6% to 9.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: OGEN has sufficient cash runway for 6 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: OGEN is forecast to have sufficient cash runway for 5 months based on free cash flow estimates, but has since raised additional capital.